IBRX icon

ImmunityBio (IBRX)

NAS

$2.80

-$0.040 (

-1.41%

)

1D
5D
1M
6M
1Y
5Y
Market closed

IBRX: $2.80 / ₿ 0 BTC / 2654 Sats

08:01 AM02:41 PM04:40 PM06:39 PM$2.65$2.69$2.73$2.77$2.81$2.85$2.90
1D
5D
1M
6M
1Y
5Y

Last updated May 19th, 2025 at 11:56PM. Log in now to access real-time pricing data.

Key statistics

$2.84
$1.83 - $7.63
$2.47B
-0.67
$2.83
$10,266,015.00
882.62M
$2.80 - $2.82
$2.67 - $2.89
Yes

What is ImmunityBio (IBRX)?

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

The ImmunityBio (IBRX) stock price has been falling

The ImmunityBio, Inc. Common Stock (IBRX) stock price today is $2.80, reflecting a -1.41% move since the market opened. The company’s market capitalization stands at $2.47B, with a daily trading volume of $10.27M shares. For investors tracking price trends, ImmunityBio, Inc. Common Stock stock has ranged between $2.67 and $2.89 today. The previous closing price was $2.84.

How to buy ImmunityBio (IBRX)

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy IBRX

Search for IBRX in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy IBRX.

IBRX FAQs

IBRX is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

IBRX is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, ImmunityBio, Inc. Common Stock (IBRX) has traded between a low of $1.83 and a high of $7.63.

IBRX is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in ImmunityBio? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
IBRX icon
IBRX

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy ImmunityBio in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

NIXXW icon

NIXXW

LNZAW icon
GIBOW icon
LIMNW icon

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.